Mercator Medical S.A. (MRC)
Warsaw Stock Exchange · Poland · prices in PLN · close of 22 Oct 2026
Key indicators
| Last close | PLN 58.70 |
|---|---|
| 52-week range | 37.00 – 63.70 |
| Return, 1 month / 3 months | +4.4% / +15.1% |
| Return, 1 year / 3 years | +45.4% / +45.0% |
| Trend | Uptrend |
| RSI (14) | 52 |
| Volatility (1 year) | 41.8% |
| Worst drawdown (1 year) | -22.0% |
| Average daily value traded | 0.61M PLN |
| Dividend yield | 2.8% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Mercator Medical S.A. is a Polish manufacturer and distributor of disposable medical gloves and other single-use medical products. The company produces examination gloves, chiefly from nitrile and latex, and supplies them under its own brands to distributors, hospitals, clinics and other healthcare customers. It also distributes related disposable medical supplies. Mercator Medical is based in Kraków, Poland, and serves customers in Poland and across international markets through its sales and distribution operations.
On this site Mercator Medical S.A. appears as a stock on the Warsaw Stock Exchange (Poland), code MRC, with prices in Polish zloty (PLN). Our dividend records, which start in 2019, show payments in 3 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Mercator Medical S.A. (MRC) trades on the Warsaw Stock Exchange in Poland. It last closed at PLN 58.70 on 22 October 2026.
Its price-based Market X-Ray is 72 out of 100 (a strong price profile), ranking 78 of 580 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 45.4% and over the last three months it rose 15.1%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Warsaw Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 87 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 16.2% | ||
| From 52-week high | -5.3% | ||
| Momentum | 81 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 15.1% | ||
| 6-month return | 12.0% | ||
| 12-month return, skipping the last month | 39.2% | ||
| Stability (higher is calmer) | 64 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 41.8% | ||
| Worst drawdown, 1 year (smaller is calmer) | -22.0% | ||
| Liquidity | 83 · Strong | Trades actively. | |
| Average daily value traded | 0.61M PLN | ||
| Zero-volume days | 0.0% | ||
| Income | 18 · Weak | Dividend is small or irregular. | |
| Dividend yield | 2.8% | ||
| Years with dividends | 2 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
- Liquidity: Trades actively.
Weak spots
- Income: Dividend is small or irregular.
Returns
| 1 week | +0.0% |
|---|---|
| 1 month | +4.4% |
| 3 months | +15.1% |
| 6 months | +12.0% |
| 1 year | +45.4% |
| 3 years | +45.0% |
| 5 years | −42.3% |
Signals
| 50-day / 200-day average | 57.73 / 50.52 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 1.60 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 21 Jul 2026 | PLN 1.6400 |
| 29 Jun 2023 | PLN 2.5000 |
| 18 Jun 2020 | PLN 0.5000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Warsaw Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.